Publications by authors named "Fatema Turkistani"

Claim this Profile
H
Health Care Resource Utilization and Costs Associated with US Medicaid Sobriety Restrictions on Direct-Acting Antivirals for Hepatitis C Virus: A Retrospective Claims Database Analysis.
Michelle T Martin, Krithika Rajagopalan, Dilip Makhija, Fatema Turkistani, Caroline Burk

Pharmacoeconomics· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmaceutical pricing benchmarks: governmental versus private sector.
Fatema Turkistani, Aseel Bin Sawad

J Comp Eff Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of venous leg ulcers using bilayered living cellular construct.
Aseel Bin Sawad, Fatema Turkistani

J Comp Eff Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Financial Impact of Alternative Pricing Benchmarks for Physician-Dispensed Drugs in the California Workers' Compensation System.
Leslie Wilson, Fatema Turkistani, Dang M Tran, Wei Huang, Tracy Kuo Lin

Appl Health Econ Health Policy· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of alternative pricing methods for drugs in California Workers' Compensation System: Fee-schedule pricing.
Leslie Wilson, Fatema A Turkistani, Wei Huang, Dang M Tran, Tracy Kuo Lin

PLoS One· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of different strategies for treatment relapsing-remitting multiple sclerosis.
Aseel Bin Sawad, Enrique Seoane-Vazquez, Rosa Rodriguez-Monguio, Fatema Turkistani

J Comp Eff Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Expanded Disability Status Scale and the Multiple Sclerosis Functional Composite as clinical endpoints in multiple sclerosis clinical trials: quantitative meta-analyses.
Aseel Bin Sawad, Enrique Seoane-Vazquez, Rosa Rodriguez-Monguio, Fatema Turkistani

Curr Med Res Opin· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Price analysis of multiple sclerosis disease-modifying therapies marketed in the United States.
Aseel Bin Sawad, Enrique Seoane-Vazquez, Rosa Rodriguez-Monguio, Fatema Turkistani

Curr Med Res Opin· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis